# Immunic, Inc. (IMUX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IMUX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -66.69M | $ -48.55M | $ 567.0K | $ 127.58M |
| 2025 | $ 0 | $ -99.50M | $ -88.02M | $ 684.0K | $ -6.67M |
| 2024 | $ 0 | $ -105.64M | $ -89.37M | $ 1.00M | $ 18.43M |
| 2023 | $ 0 | $ -101.22M | $ -76.94M | $ 1.33M | $ 28.93M |
| 2022 | $ 0 | $ -134.51M | $ -72.90M | $ 1.56M | $ 113.68M |
| 2021 | $ 0 | $ -110.48M | $ -99.01M | $ 992.0K | $ 127.12M |
| 2020 | $ 0 | $ -56.07M | $ -58.94M | $ 976.0K | $ 158.79M |
| 2019 | $ 0 | $ -51.78M | $ -36.92M | $ 520.0K | $ 58.36M |
| 2018 | $ 0 | $ -54.78M | $ -57.80M | $ 0 | $ 12.43M |
| 2017 | $ 0 | $ -70.16M | $ -55.34M | $ 0 | $ 50.04M |
| 2016 | $ 0 | $ -56.37M | $ -49.98M | $ 0 | $ 58.45M |
| 2015 | $ 0 | $ -73.04M | $ -73.42M | $ 0 | $ 82.33M |
| 2014 | $ 0 | $ -67.35M | $ -59.68M | $ 0 | $ 97.56M |
| 2013 | $ 0 | $ -46.53M | $ -42.85M | $ 0 | $ 41.42M |
| 2012 | $ 0 | $ -4.41M | $ -8.33M | $ 0 | $ -7.63M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.25 |
| Current Ratio | 5.05 |

## Other views

- [Metrics](https://sponda.capital/en/IMUX.md)
- [Charts](https://sponda.capital/en/IMUX/charts.md)
- [Compare](https://sponda.capital/en/IMUX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.